Merck’s Enflonsia will go up against Sanofi and AstraZeneca’s Beyfortus, which the partners plan to ship out early in the third quarter.

Antibodies from B cells mediate complement-dependent cytotoxicity ... Additionally, B cells present antigens to T cells and secrete cytokines like IFN-γ and CXCL13, amplifying anti-tumor immunity.

Blood clots form in response to signals from the lungs of cancer patients -- not from other organ sites, as previously thought -- according to a preclinical study. Clots are the second-leading ...

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.

Borrelia burgdorferi antibody index showed no significant (p=0.356) change over follow-up. Conclusions The study confirms the relevance of CXCL13 as a diagnostic biomarker of NB and suggests that CSF ...

Here, we designed a general strategy to improve the magnitude and breadth of the antibody response induced by circRNA vaccines and remodeled the immune microenvironment of lymph nodes by integrating ...

Overall, the circRNA-based antigen-CXCL13 coexpression system developed herein provides a simple and robust platform that enhances the magnitude and breadth of antibody responses against multiple ...

Discover how Vaccinex Inc's anti-CXCL13 monoclonal antibodies are revolutionizing treatment for autoimmune diseases, inflammation, and cancer. Explore the groundbreaking patent now!

A newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis.

A newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis. The ...